Reports
Sale
Global Preventive Healthcare Technologies and Services Market: By Type: Early Detection and Screening, Vaccines, Chronic Diseases Management, Advanced Technologies to Reduce Errors; By Application: Hospitals, Clinics, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Model; Supplier Landscape; 2024-2032
Global Preventive Healthcare Technologies and Services Market Outlook
The global preventive healthcare technologies and services market size was valued at USD 266.5 million in 2023, driven by the growing geriatric population and increasing prevalence of chronic diseases. The market size is anticipated to grow at a CAGR of 12.6% during the forecast period of 2024-2032 to achieve a value of USD 776.6 million by 2032.
Preventive Healthcare Technologies and Services: Introduction
Preventive healthcare technologies and services help in the early detection and prevention of medical conditions. These medical conditions can be critical or temporary. Preventive healthcare technologies are the devices used to measure health patterns such as sleep, blood pressure, heart rate, blood oxygen, and blood sugar, among other patterns. These patterns can help identify the future risks associated with current medical conditions and help prevent them. Some preventive healthcare technologies include blood pressure monitors, non-invasive glucometers, scales, step counters, digital weighing machines, and body fat analyzers.
Preventive healthcare services are practices that help prevent and detect serious medical conditions. These services include annual check-ups, vaccinations, regular screening for chronic conditions like diabetes and heart disease, immunizations against serious illnesses like flu and COVID-19, and screenings such as mammograms and colonoscopies, blood pressure, diabetes, and cholesterol tests.
Global Preventive Healthcare Technologies and Services Market Analysis
The FDA approved a new Beta Bionics iLet ACE Pump and algorithm-based software iLet Dosing Decision Software to diagnose the condition in people aged 6 years and above with diabetes. It is also announced that these will be coupled along with a compatible FDA-cleared integrated continuous glucose monitor (iCGM) to form a new system which will be known as the iLet Bionic Pancreas. This automated insulin dosing (AID) system uses an algorithm to determine insulin delivery. Such innovative developments in the field are anticipated to influence the global preventive healthcare technologies and services market growth.
The increased focus of most key players on the development of innovative technologies to reduce the hassle for the consumer and provide the best patient outcomes is a major factor driving the market growth. According to the World Health Organization, nearly 422 million people worldwide are currently suffering from diabetes. With a huge number as mentioned, the demand for these technologically advanced preventive healthcare technologies and services is also expected to increase and it will directly influence the market growth during the forecast period.
Preventive Healthcare Technologies and Services Market Segmentations
Market Breakup by Type
- Early Detection and Screening
- Vaccines
- Chronic Diseases Management
- Advanced Technologies to Reduce Errors
Market Breakup by Application
- Hospitals
- Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Preventive Healthcare Technologies and Services Market Overview
The growth of the market is driven by the increasing prevalence of chronic diseases, coupled with the rapidly rising geriatric population. With people adopting sedentary lifestyles and increasing disposable incomes in countries, especially developing countries, the market for preventive healthcare technologies and services is expected to grow at a rapid pace. Increasing technological advancements in the development of healthcare equipment are also driving market growth as they are responsible for the increased popularity of such devices and services.
Additionally, the increasing focus of market key players on the development of affordable and effective products and devices is acting as a contributing factor to the preventive healthcare technologies and services market growth. The easy availability of these preventive healthcare products has collectively contributed to the increased popularity and awareness about the benefits of using them as they save a lot of money and provide the best service at the user’s convenience.
North America is currently dominating the global market and is expected to dominate in the forecast period. The growth of the regional market is driven by the presence of some of the major key players. The presence of advanced healthcare technologies in the region and a greatly developed healthcare system are the key factors responsible for market growth. Continuous government efforts toward enlightening the regional population are also bolstering the market growth.
Preventive Healthcare Technologies and Services Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Myriad Genetics, Inc
- Quest Diagnostics Incorporated
- Medtronic
- Abbott
- Merck & Co., Inc
- GlaxoSmithKline plc
- Pfizer Inc. (U.S.)
- Omnicell, Inc
- McKesson Corporation
- Dilon Medical Technologies, Inc.
- OMRON Healthcare Europe B.V.
- Novx Systems, Corp.
- Sanofi
- Viatronix, Inc.
- Lifecom, Inc.
Please note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Preventive Healthcare Technologies and Services Market Overview
3.1 Global Preventive Healthcare Technologies and Services Market Historical Value (2017-2023)
3.2 Global Preventive Healthcare Technologies and Services Market Forecast Value (2024-2032)
4 Global Preventive Healthcare Technologies and Services Market Landscape
4.1 Global Preventive Healthcare Technologies and Services Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Preventive Healthcare Technologies and Services Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Application
5 Global Preventive Healthcare Technologies and Services Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Preventive Healthcare Technologies and Services Market Segmentation
6.1 Global Preventive Healthcare Technologies and Services Market by Type
6.1.1 Market Overview
6.1.2 Early Detection and Screening
6.1.3 Vaccines
6.1.4 Chronic Diseases Management
6.1.5 Advanced Technologies to Reduce Errors
6.2 Global Preventive Healthcare Technologies and Services Market by Application
6.2.1 Market Overview
6.2.2 Hospitals
6.2.3 Clinics
6.2.4 Others
6.3 Global Preventive Healthcare Technologies and Services Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Preventive Healthcare Technologies and Services Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Preventive Healthcare Technologies and Services Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Preventive Healthcare Technologies and Services Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Preventive Healthcare Technologies and Services Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Preventive Healthcare Technologies and Services Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Myriad Genetics, Inc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Quest Diagnostics Incorporated
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Medtronic
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Abbott
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Merck & Co., Inc
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 GlaxoSmithKline plc
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Pfizer Inc. (U.S.)
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Omnicell, Inc
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 McKesson Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Dilon Medical Technologies, Inc.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 OMRON Healthcare Europe B.V.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Novx Systems, Corp.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Sanofi
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Viatronix, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Lifecom, Inc.
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Preventive Healthcare Technologies and Services Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 266.5 million in 2023, driven by rapid innovation in the market.
The market is anticipated to grow at a CAGR of 12.6% during the forecast period of 2024-2032 and is likely to reach a market value of USD 776.6 million by 2032.
What are the major factors aiding the preventive healthcare technologies and services market demand?
The increasing number of diabetic and hypertension patients worldwide is a major factor driving the market demand.
The increasing efforts and developments of technologically advanced preventive healthcare technologies and services is a major trend influencing market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different types of preventive healthcare technologies and services include early detection and screening, vaccines, chronic disease management, and advanced technologies to reduce errors.
They find wide applications in hospitals and clinics, among others.
Key players involved in the market are Myriad Genetics, Inc., Quest Diagnostics Incorporated, Medtronic, Abbott, Merck & Co., Inc, GlaxoSmithKline plc, Pfizer Inc. (U.S.), Omnicell, Inc, McKesson Corporation, Dilon Medical Technologies, Inc., OMRON Healthcare Europe B.V., Novx Systems, Corp., Lifecom, Inc., Viatronix, Inc., and Sanofi.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER